Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Capital Leases (2017 - 2025)

Historic Capital Leases for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2025 value amounting to $2.1 million.

  • Organogenesis Holdings' Capital Leases rose 10549.56% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 10549.56%. This contributed to the annual value of $718000.0 for FY2024, which is 6197.03% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Capital Leases of $2.1 million as of Q3 2025, which was up 10549.56% from $98000.0 recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Capital Leases high stood at $10.5 million for Q1 2021, and its period low was $98000.0 during Q2 2025.
  • Moreover, its 4-year median value for Capital Leases was $1.3 million (2024), whereas its average is $2.5 million.
  • Its Capital Leases has fluctuated over the past 5 years, first crashed by 9321.02% in 2021, then soared by 22686.57% in 2024.
  • Over the past 4 years, Organogenesis Holdings' Capital Leases (Quarter) stood at $831000.0 in 2021, then skyrocketed by 127.2% to $1.9 million in 2023, then tumbled by 61.97% to $718000.0 in 2024, then soared by 191.64% to $2.1 million in 2025.
  • Its last three reported values are $2.1 million in Q3 2025, $98000.0 for Q2 2025, and $411000.0 during Q1 2025.